Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Gorilla Technology
GRRR
US Stock MarketDetailed Quotes
RIGL Rigel Pharmaceuticals
- 19.490
- -0.040-0.20%
Close Mar 11 16:00 ET
- 19.490
- 0.0000.00%
Post 16:12 ET
348.15MMarket Cap19.69P/E (TTM)
19.880High18.528Low288.19KVolume19.510Open19.530Pre Close5.57MTurnover1.88%Turnover Ratio19.69P/E (Static)17.86MShares29.82052wk High105.92P/B298.98MFloat Cap7.48452wk Low--Dividend TTM15.34MShs Float1147.499Historical High--Div YieldTTM6.92%Amplitude6.400Historical Low19.337Avg Price1Lot Size
Rigel Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 53.38%179.28M | 60.92%57.6M | 96.58%55.31M | 37.03%36.84M | 13.29%29.53M | -2.79%116.88M | -30.20%35.79M | 25.54%28.13M | -9.84%26.89M | 55.78%26.07M |
| Operating revenue | 53.03%244.3M | 60.74%77.27M | 83.64%72.7M | 43.64%52.37M | 18.11%41.96M | 5.00%159.65M | -21.19%48.07M | 31.10%39.59M | 22.27%36.46M | 112.27%35.52M |
| Cost of revenue | 162.26%18.65M | 52.74%5.79M | 532.97%8.03M | 161.12%2.81M | 107.27%2.03M | 306.52%7.11M | 1,008.19%3.79M | 407.20%1.27M | 3.76%1.08M | 707.44%977K |
| Gross profit | 46.33%160.63M | 61.89%51.81M | 75.99%47.28M | 31.86%34.03M | 9.63%27.51M | -7.36%109.77M | -37.17%32M | 21.24%26.87M | -10.33%25.81M | 51.04%25.09M |
| Operating expense | 4.74%136.44M | 17.03%35.15M | 6.05%33.23M | 8.07%33.59M | -8.84%34.48M | -24.58%130.26M | -36.82%30.04M | -22.76%31.33M | -25.56%31.08M | -11.79%37.82M |
| Selling and administrative expenses | 6.92%113.06M | 9.94%29.52M | 8.80%27.04M | 6.62%28.05M | 2.60%28.45M | -5.97%105.74M | -16.54%26.85M | -4.02%24.86M | -2.50%26.31M | 1.20%27.73M |
| Research and development costs | -4.66%23.38M | 76.77%5.63M | -4.53%6.18M | 16.09%5.54M | -40.27%6.03M | -59.31%24.52M | -79.26%3.19M | -55.85%6.48M | -67.68%4.77M | -34.80%10.09M |
| Operating profit | 218.06%24.19M | 747.15%16.66M | 414.80%14.06M | 108.49%447K | 45.26%-6.97M | 62.21%-20.49M | -42.16%1.97M | 75.74%-4.47M | 59.38%-5.27M | 51.54%-12.73M |
| Net non-operating interest income expense | -26.65%-5.83M | -16.60%-1.43M | -33.25%-1.64M | -10.80%-1.48M | -57.95%-1.28M | -52.17%-4.6M | -81.27%-1.23M | -93.53%-1.23M | -152.94%-1.33M | 31.50%-811K |
| Non-operating interest income | -7.92%2.09M | -23.01%522K | -36.76%425K | 4.35%552K | 50.89%593K | 232.16%2.27M | 58.04%678K | 250.00%672K | 1,159.52%529K | 1,771.43%393K |
| Non-operating interest expense | 15.22%7.92M | 2.52%1.96M | 8.48%2.06M | 8.97%2.03M | 55.65%1.87M | 85.38%6.87M | 72.27%1.91M | 129.90%1.9M | 227.24%1.86M | -0.08%1.2M |
| Other net income (expense) | ||||||||||
| Special income (charges) | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less：Restructuring and merger&acquisition | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Income before tax | 173.20%18.37M | 1,965.40%15.22M | 318.22%12.42M | 84.39%-1.03M | 39.07%-8.25M | 57.16%-25.09M | -47.39%737K | 70.10%-5.69M | 51.08%-6.6M | 50.68%-13.54M |
| Income tax | 881K | 0 | ||||||||
| Net income | 169.69%17.49M | 1,845.86%14.34M | 318.22%12.42M | 84.39%-1.03M | 39.07%-8.25M | 57.16%-25.09M | -47.39%737K | 70.10%-5.69M | 51.08%-6.6M | 50.68%-13.54M |
| Net income continuous Operations | 169.69%17.49M | 1,845.86%14.34M | 318.22%12.42M | 84.39%-1.03M | 39.07%-8.25M | 57.16%-25.09M | -47.39%737K | 70.10%-5.69M | 51.08%-6.6M | 50.68%-13.54M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 169.69%17.49M | 1,845.86%14.34M | 318.22%12.42M | 84.39%-1.03M | 39.07%-8.25M | 57.16%-25.09M | -47.39%737K | 70.10%-5.69M | 51.08%-6.6M | 50.68%-13.54M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 169.69%17.49M | 1,845.86%14.34M | 318.22%12.42M | 84.39%-1.03M | 39.07%-8.25M | 57.16%-25.09M | -47.39%737K | 70.10%-5.69M | 51.08%-6.6M | 50.68%-13.54M |
| Basic earnings per share | 168.75%0.99 | 1,520.00%0.81 | 315.15%0.71 | 84.21%-0.06 | 37.50%-0.5 | 58.14%-1.44 | -50.00%0.05 | 70.00%-0.33 | 52.50%-0.38 | 50.00%-0.8 |
| Diluted earnings per share | 168.75%0.99 | 1,500.00%0.8 | 312.12%0.7 | 84.21%-0.06 | 37.50%-0.5 | 58.14%-1.44 | -50.00%0.05 | 70.00%-0.33 | 52.50%-0.38 | 50.00%-0.8 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |